View ValuationAvenira 将来の成長Future 基準チェック /06現在、 Aveniraの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Metals and Mining 収益成長13.4%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Feb 27Avenira Limited has filed a Follow-on Equity Offering in the amount of AUD 8.785842 million.Avenira Limited has filed a Follow-on Equity Offering in the amount of AUD 8.785842 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,171,445,635 Price\Range: AUD 0.0075お知らせ • Oct 24Avenira Limited, Annual General Meeting, Nov 25, 2025Avenira Limited, Annual General Meeting, Nov 25, 2025. Location: at level 1, suite 9, 110 hay st, subiaco, wa 6008 Australiaお知らせ • Mar 10Avenira Limited has filed a Follow-on Equity Offering in the amount of AUD 7.567 million.Avenira Limited has filed a Follow-on Equity Offering in the amount of AUD 7.567 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,081,000,000 Price\Range: AUD 0.007 Transaction Features: Subsequent Direct Listingお知らせ • Dec 03Avenira Limited has completed a Follow-on Equity Offering in the amount of AUD 4.5 million.Avenira Limited has completed a Follow-on Equity Offering in the amount of AUD 4.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 285,000,000 Price\Range: AUD 0.006 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 465,000,000 Price\Range: AUD 0.006 Transaction Features: Subsequent Direct Listingお知らせ • Oct 30Avenira Limited, Annual General Meeting, Nov 29, 2024Avenira Limited, Annual General Meeting, Nov 29, 2024. Location: physical meeting at: unit 12 / 217 hay st, subiaco, wa 6008 Australiaお知らせ • Sep 10Avenira Limited Announces Board ChangesAvenira Limited advised that following an internal transfer/promotion by major shareholder Hebang Biotechnology, Mr. Mo Yang has resigned as a director of Avenira and has been replaced by Ms Yuan (Stephanie) Yuan. Ms Yuan has been a Board Secretary and Board member of various Hebang companies over the past 10 years. Ms Yuan has a Master of Management Accounting and a Master Of Philosophy from Melbourne University, and a Bachelor of Medicine from Tongji University in China. Role: Ms Yuan will undertake the role of Chairman and Chief Executive Officer providing strategic funding, managerial operation and technical expertise and knowhow to the company including performing all duties from time to time vested in or assigned to her by the Board. Role: Ms Yuan will undertake the role of Chairman and Chief Executive Officer providing strategic funding, managerial operation and technical expertise and knowhow to the company including performing all duties from time to time vested in or assigned to her by the Board.お知らせ • Jul 03Avenira Limited Announces Board ResignationsAvenira Limited announced that Directors Mr. Kevin Dundo and Ms. Winnie Lai Hadad have resigned from the Board of Directors effective July 2, 2024.お知らせ • Apr 05Avenira Limited has completed a Follow-on Equity Offering in the amount of AUD 1.2517 million.Avenira Limited has completed a Follow-on Equity Offering in the amount of AUD 1.2517 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 156,462,500 Price\Range: AUD 0.008 Discount Per Security: AUD 0.00048 Transaction Features: Subsequent Direct Listingお知らせ • Apr 04Avenira Limited has filed a Follow-on Equity Offering in the amount of AUD 1.2517 million.Avenira Limited has filed a Follow-on Equity Offering in the amount of AUD 1.2517 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 156,462,500 Price\Range: AUD 0.008 Discount Per Security: AUD 0.00048 Transaction Features: Subsequent Direct Listingお知らせ • Mar 18Avenira Limited has completed a Follow-on Equity Offering in the amount of AUD 10.97 million.Avenira Limited has completed a Follow-on Equity Offering in the amount of AUD 10.97 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 137,125,000 Price\Range: AUD 0.08 Discount Per Security: AUD 0.0048 Transaction Features: Subsequent Direct Listingお知らせ • Dec 13Avenira Limited announced that it has received AUD 2 million in funding from Sichuan Hebang Biotechnology Corporation LimitedOn December 11, 2023, Avenira Limited closed the transaction.お知らせ • Dec 07Avenira Limited has completed a Follow-on Equity Offering in the amount of AUD 5.008457 million.Avenira Limited has completed a Follow-on Equity Offering in the amount of AUD 5.008457 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 181,818,182 Price\Range: AUD 0.011 Discount Per Security: AUD 0.00066 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 252,496,129 Price\Range: AUD 0.011 Discount Per Security: AUD 0.00066 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 21,000,000 Price\Range: AUD 0.011 Discount Per Security: AUD 0.00066 Transaction Features: Subsequent Direct Listingお知らせ • Dec 06Avenira Limited has filed a Follow-on Equity Offering in the amount of AUD 2 million.Avenira Limited has filed a Follow-on Equity Offering in the amount of AUD 2 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 181,818,182 Price\Range: AUD 0.011 Transaction Features: Subsequent Direct Listingお知らせ • Dec 05Avenira Limited announced that it expects to receive AUD 2 million in funding from Sichuan Hebang Biotechnology Corporation LimitedAvenira Limited announced that it has entered into a share purchase agreement to issue 181,818,182 common shares at a price of AUD 0.011 per share for the gross proceeds of AUD 2,000,000 on December 4, 2023. The transaction will include participation from new investor, Sichuan Hebang Biotechnology Corporation Limited. Post the completion of the transaction, the investor, will become a substantial shareholder in the issued capital of the company. The placement will be completed in one tranche.お知らせ • Oct 31Avenira Limited, Annual General Meeting, Nov 29, 2023Avenira Limited, Annual General Meeting, Nov 29, 2023, at 13:30 W. Australia Standard Time. Location: Level 1, Suite 9, 110 Hay Street, Subiaco, WA Subiaco Australia Agenda: To receive and consider the Annual Report of the Company for the year ended 30 June 2023, which includes the Financial Report, the Directors' Report (including the Remuneration Report) and the Auditor's Report; to consider Adoption of Remuneration Report; to consider Re-election of Mr Brett Clark as a Director; to consider Re-election of Mr Roger Harris as a Director; to consider Election of Mr Nam (Eddy) Cheng as a Director; to consider Ratification of Issue of Securities; to consider Approval for the Issue of Lead Manager Options to Petra Capital Pty Ltd; and to consider other business matters.お知らせ • Jun 22Avenira Limited Announces Board ChangesAvenira Limited announces the resignation of Dr Geoffrey Xue as a director of the Company. On 14 June 2021 shareholder approval was obtained in relation to the $3 million Convertible Loan Agreement between the Company and Au Xingao Investment Pty Ltd, as Lender (Au Xingao). The notice of meeting set out that under the Convertible Loan Agreement the Lender could nominate two persons to be directors of the Company. On 9 July 2021 Mr. Roger Harris was appointed as a nominee of the Lender and the second nominee Dr Geoffrey Xue was appointed on 21 July 2021. While the loan remains payable on or before 8 March 2024, the Lender can maintain two nominee directors on the Company's board and if one or both resign the Lender can nominate a replacement. Due to other commitments Dr Geoffrey Xue has tendered his resignation as a director of the Company. The Company wishes to thank Dr Xue for his contribution over the last two years and in particular his expertise in geological and technical fields that has been highly valued by the Board. Au Xingao has nominated Mr. Eddy Cheng as the replacement for Dr Xue. Mr. Cheng's experience has been in business development, strategic planning and market analysis and will add a further skilllset to the Board as it seeks to develop the Wonarah Project.お知らせ • May 25Avenira Limited has completed a Follow-on Equity Offering in the amount of AUD 5 million.Avenira Limited has completed a Follow-on Equity Offering in the amount of AUD 5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 281,763,677 Price\Range: AUD 0.011 Discount Per Security: AUD 0.00066 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 172,781,778 Price\Range: AUD 0.011 Discount Per Security: AUD 0.00066 Transaction Features: Subsequent Direct Listing このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Avenira は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測OTCPK:MMMK.F - アナリストの将来予測と過去の財務データ ( )AUD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20250-2-5-3N/A9/30/20250-3-6-3N/A6/30/2025N/A-5-6-3N/A3/31/2025N/A-6-6-2N/A12/31/2024N/A-7-6-2N/A9/30/2024N/A-5-6-2N/A6/30/2024N/A-3-6-1N/A3/31/20240-3-6-2N/A12/31/20230-2-6-2N/A9/30/20230-3-5-2N/A6/30/20230-3-5-2N/A3/31/20230-4-4-2N/A12/31/20220-4-4-2N/A9/30/20220-4-4-2N/A6/30/20220-3-3-2N/A3/31/20220-3-3-1N/A12/31/2021N/A-2-3-1N/A9/30/20210-2-3-2N/A6/30/20210-2-3-2N/A12/31/20200-3-3-2N/A9/30/20200-3-4-3N/A6/30/2020N/A-3-5-4N/A12/31/2019N/A4-8-6N/A9/30/2019N/A4N/A-5N/A6/30/2019N/A5N/A-4N/A12/31/20180-2N/A-4N/A9/30/20180-2N/A-4N/A6/30/2018N/A-2N/A-4N/A3/31/20180-9N/A-3N/A12/31/20170-12N/A-2N/A9/30/20170-20N/A-5N/A6/30/20170-27N/A-7N/A3/31/20171-24N/A-9N/A12/31/20161-20N/A-10N/A9/30/20161-14N/A-9N/A6/30/20161-9N/A-7N/A3/31/20161-28N/A-7N/A12/31/20151-47N/A-7N/A9/30/20151-45N/A-6N/A6/30/20151-43N/A-5N/A3/31/20151-23N/A-4N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: MMMK.Fの予測収益成長が 貯蓄率 ( 3.4% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: MMMK.Fの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: MMMK.Fの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: MMMK.Fの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: MMMK.Fの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: MMMK.Fの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/03/17 17:35終値2025/12/18 00:00収益2025/12/31年間収益2025/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Avenira Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Feb 27Avenira Limited has filed a Follow-on Equity Offering in the amount of AUD 8.785842 million.Avenira Limited has filed a Follow-on Equity Offering in the amount of AUD 8.785842 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,171,445,635 Price\Range: AUD 0.0075
お知らせ • Oct 24Avenira Limited, Annual General Meeting, Nov 25, 2025Avenira Limited, Annual General Meeting, Nov 25, 2025. Location: at level 1, suite 9, 110 hay st, subiaco, wa 6008 Australia
お知らせ • Mar 10Avenira Limited has filed a Follow-on Equity Offering in the amount of AUD 7.567 million.Avenira Limited has filed a Follow-on Equity Offering in the amount of AUD 7.567 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,081,000,000 Price\Range: AUD 0.007 Transaction Features: Subsequent Direct Listing
お知らせ • Dec 03Avenira Limited has completed a Follow-on Equity Offering in the amount of AUD 4.5 million.Avenira Limited has completed a Follow-on Equity Offering in the amount of AUD 4.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 285,000,000 Price\Range: AUD 0.006 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 465,000,000 Price\Range: AUD 0.006 Transaction Features: Subsequent Direct Listing
お知らせ • Oct 30Avenira Limited, Annual General Meeting, Nov 29, 2024Avenira Limited, Annual General Meeting, Nov 29, 2024. Location: physical meeting at: unit 12 / 217 hay st, subiaco, wa 6008 Australia
お知らせ • Sep 10Avenira Limited Announces Board ChangesAvenira Limited advised that following an internal transfer/promotion by major shareholder Hebang Biotechnology, Mr. Mo Yang has resigned as a director of Avenira and has been replaced by Ms Yuan (Stephanie) Yuan. Ms Yuan has been a Board Secretary and Board member of various Hebang companies over the past 10 years. Ms Yuan has a Master of Management Accounting and a Master Of Philosophy from Melbourne University, and a Bachelor of Medicine from Tongji University in China. Role: Ms Yuan will undertake the role of Chairman and Chief Executive Officer providing strategic funding, managerial operation and technical expertise and knowhow to the company including performing all duties from time to time vested in or assigned to her by the Board. Role: Ms Yuan will undertake the role of Chairman and Chief Executive Officer providing strategic funding, managerial operation and technical expertise and knowhow to the company including performing all duties from time to time vested in or assigned to her by the Board.
お知らせ • Jul 03Avenira Limited Announces Board ResignationsAvenira Limited announced that Directors Mr. Kevin Dundo and Ms. Winnie Lai Hadad have resigned from the Board of Directors effective July 2, 2024.
お知らせ • Apr 05Avenira Limited has completed a Follow-on Equity Offering in the amount of AUD 1.2517 million.Avenira Limited has completed a Follow-on Equity Offering in the amount of AUD 1.2517 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 156,462,500 Price\Range: AUD 0.008 Discount Per Security: AUD 0.00048 Transaction Features: Subsequent Direct Listing
お知らせ • Apr 04Avenira Limited has filed a Follow-on Equity Offering in the amount of AUD 1.2517 million.Avenira Limited has filed a Follow-on Equity Offering in the amount of AUD 1.2517 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 156,462,500 Price\Range: AUD 0.008 Discount Per Security: AUD 0.00048 Transaction Features: Subsequent Direct Listing
お知らせ • Mar 18Avenira Limited has completed a Follow-on Equity Offering in the amount of AUD 10.97 million.Avenira Limited has completed a Follow-on Equity Offering in the amount of AUD 10.97 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 137,125,000 Price\Range: AUD 0.08 Discount Per Security: AUD 0.0048 Transaction Features: Subsequent Direct Listing
お知らせ • Dec 13Avenira Limited announced that it has received AUD 2 million in funding from Sichuan Hebang Biotechnology Corporation LimitedOn December 11, 2023, Avenira Limited closed the transaction.
お知らせ • Dec 07Avenira Limited has completed a Follow-on Equity Offering in the amount of AUD 5.008457 million.Avenira Limited has completed a Follow-on Equity Offering in the amount of AUD 5.008457 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 181,818,182 Price\Range: AUD 0.011 Discount Per Security: AUD 0.00066 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 252,496,129 Price\Range: AUD 0.011 Discount Per Security: AUD 0.00066 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 21,000,000 Price\Range: AUD 0.011 Discount Per Security: AUD 0.00066 Transaction Features: Subsequent Direct Listing
お知らせ • Dec 06Avenira Limited has filed a Follow-on Equity Offering in the amount of AUD 2 million.Avenira Limited has filed a Follow-on Equity Offering in the amount of AUD 2 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 181,818,182 Price\Range: AUD 0.011 Transaction Features: Subsequent Direct Listing
お知らせ • Dec 05Avenira Limited announced that it expects to receive AUD 2 million in funding from Sichuan Hebang Biotechnology Corporation LimitedAvenira Limited announced that it has entered into a share purchase agreement to issue 181,818,182 common shares at a price of AUD 0.011 per share for the gross proceeds of AUD 2,000,000 on December 4, 2023. The transaction will include participation from new investor, Sichuan Hebang Biotechnology Corporation Limited. Post the completion of the transaction, the investor, will become a substantial shareholder in the issued capital of the company. The placement will be completed in one tranche.
お知らせ • Oct 31Avenira Limited, Annual General Meeting, Nov 29, 2023Avenira Limited, Annual General Meeting, Nov 29, 2023, at 13:30 W. Australia Standard Time. Location: Level 1, Suite 9, 110 Hay Street, Subiaco, WA Subiaco Australia Agenda: To receive and consider the Annual Report of the Company for the year ended 30 June 2023, which includes the Financial Report, the Directors' Report (including the Remuneration Report) and the Auditor's Report; to consider Adoption of Remuneration Report; to consider Re-election of Mr Brett Clark as a Director; to consider Re-election of Mr Roger Harris as a Director; to consider Election of Mr Nam (Eddy) Cheng as a Director; to consider Ratification of Issue of Securities; to consider Approval for the Issue of Lead Manager Options to Petra Capital Pty Ltd; and to consider other business matters.
お知らせ • Jun 22Avenira Limited Announces Board ChangesAvenira Limited announces the resignation of Dr Geoffrey Xue as a director of the Company. On 14 June 2021 shareholder approval was obtained in relation to the $3 million Convertible Loan Agreement between the Company and Au Xingao Investment Pty Ltd, as Lender (Au Xingao). The notice of meeting set out that under the Convertible Loan Agreement the Lender could nominate two persons to be directors of the Company. On 9 July 2021 Mr. Roger Harris was appointed as a nominee of the Lender and the second nominee Dr Geoffrey Xue was appointed on 21 July 2021. While the loan remains payable on or before 8 March 2024, the Lender can maintain two nominee directors on the Company's board and if one or both resign the Lender can nominate a replacement. Due to other commitments Dr Geoffrey Xue has tendered his resignation as a director of the Company. The Company wishes to thank Dr Xue for his contribution over the last two years and in particular his expertise in geological and technical fields that has been highly valued by the Board. Au Xingao has nominated Mr. Eddy Cheng as the replacement for Dr Xue. Mr. Cheng's experience has been in business development, strategic planning and market analysis and will add a further skilllset to the Board as it seeks to develop the Wonarah Project.
お知らせ • May 25Avenira Limited has completed a Follow-on Equity Offering in the amount of AUD 5 million.Avenira Limited has completed a Follow-on Equity Offering in the amount of AUD 5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 281,763,677 Price\Range: AUD 0.011 Discount Per Security: AUD 0.00066 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 172,781,778 Price\Range: AUD 0.011 Discount Per Security: AUD 0.00066 Transaction Features: Subsequent Direct Listing